Table 4 Candidate regions identified by hapFLK test along with genes involving in these regions.
Scaffolds | Position (bp) | Group | Lowest q-value | Gene symbols | Overlapping statusa |
|---|---|---|---|---|---|
1 | 9,129,632–9,979,233 | Survival | 0.023 | BMP4, CDKN3, CNIH1, GMFB, CGRRF1, SAMD4A | – |
10 | 915,739–1,126,382 | Survival | 0.004 | AJAP1 | – |
1 | 23,046,774–23,187,210 | Antibody titer | 0.034 | SRSF5, SLC10A1 | × |
2 | 23,424,424–23,969,935 | Antibody titer | 0.022 | RNF165, LOXHD1, SKOR2 | × |
3 | 4,297,807–4,310,786 | Viremia-350 | 0.048 | WWP2 | – |
4 | 16,076,915–16,196,438 | Viremia-350 | 0.034 | PTPRZ1 | – |
4 | 10,514,110–10,841,037 | Kidney lesions | 0.037 | KLHDC10, ZC3HC1, UBE2H | × |
8 | 3,478,058–4,850,122 | Kidney lesions | 0.023 | SULF2, EYA2, SLC2A10, TP53RK, SLC35C2 | × |
36 | 5,250,514–5,725,445 | Kidney lesions | 0.035 | ATE1, NSMCE4A, TACC2 | – |
8 | 3,620,504–5,308,341 | Virus clearance | 0.025 | SULF2, EYA2, SLC2A10, TP53RK, SLC35C2, PLTP, MMP-9, CTSA, ELMO2 , OCSTAMP, UBE2C, ACOT8 | × |
